TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT01709396

ED-TBI Followed By Allogeneic Stem Cell Transplantation For The Treatment Of Refractory AML And Advanced MDS

Cause of deathFutility, also staffing, sites or logistics Automatic label, confidence 0.6, unverified. How labels are made.
“initial on hold due to space but now permanently suspended due to futility.”

The sponsor’s own words in the registry.

Life of this trial

2012201320142015201620172018Started2012-01Registered2012-10-12Primary completion2016-01Suspended (as of)2017-01-12

Vital statistics

Status
Suspended
Phase
Phase 2
Sponsor
Ottawa Hospital Research Institute
Sponsor type
University, hospital or other
Conditions
Acute Leukemia; Myelodysplastic Syndrome
Interventions
ED-TBI
Participants
20 (planned, not actual)
Sites
1
Countries
Canada

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.